Consierable effort has been focused on devising methods for pulating tumour oxygenation and thereby improing tumour radiosensitivity. The combination of nicotnamid 
al studies have attempted to improve tumour radioresponse through the enhancement of tumour oxygenation. Several recent reports have indicated that either carbogen breathing (95% oxygen, 5% carbon dioxide) or nicotinamide (NIC) administration, alone or in combination, can effectively radiosensitise tumours in mice (Rojas, 1991; Chaplin et al., 1993; Simon et al., 1993; Siemann et al., 1994; Done et al., 1994; Martin et al., 1994) . It is generally believed that carbogen breathing improves response by increasing the amount of oxygen physically dissolved in the blood, thereby increasing the distance the oxygen is able to diffuse from the blood vessels to the tumour cells, and possibly by increasing tumour blood flow (Kruuv et al., 1967) . NIC, on the other hand, has been suggested to increase tumour oxygenation by reducing temporal fluctuations in tumour blood flow (Chaplin et al., , 1991 Horsman et al., 1990) in addition to increasing tumour blood flow (Horsman et al., 1989; Stone et al., 1992; Kelleher and Vaupel, 1993) .
Although previous studies have generally shown the greatest enhancement of radiosensitivity following the combination of NIC and carbogen, results are highly variable among different tumour models and laboratories. For example, in the CaNT mouse mammary carcinoma (Kjellen et al., 1991) , NIC demonstrated no significant effect, while carbogen and the combination showed equivalent enhancements. In the KHT sarcoma, the treatments had similar effects when delivered under optimum conditions . Finally, in the SCCVII carcinoma, carbogen and NIC were equivalent, while the combination was superior (Chaplin et al., 1993) . Measurements of alterations in tumour oxygenation following these agents have also varied markedly with tumour line (Lee and Song, 1992; Fenton and Boyce, 1993 ; Kelleher and Vaupel, 1993; Horsman et al., 1995; Martin et al., 1994) . A key question is whether a relationship exists between direct measures of tumour oxygenation and corresponding determinations of tumour radiosensitivity. Since tumour radiosensitivity is commonly calculated from the ratio of the fraction of anoxic clonogenic tumour cells to the fraction of total clonogenic cells (Moulder and Rockwell, 1984) , it follows that if substantially different proportions of clonogenic and non-clonogenic tumour cells are oxygenated by the alternative treatments, direct measures of tumour oxygenation will not correlate with changes in radiosensitivity (Fenton et al., 1995) . Thus, although clear relationships may be demonstrated within specific tumour lines (Rofstad et al., 1988; Horsman et al., 1993) , attempts to define smilar correlations across tumour lines have proven unsuccessful (Rofstad et al., 1988; Horsman et al., 1995; Martin et al., 1994) .
The objective of the current study was to define further the physiological mechanisms responsible for the inter-tumour differences in response to these two agents. saturations were determined cryospecophotomerically as previously described (Fenton and Gayeski, 1990 Although this is a somewhat arbitrary HbO2 cut-off, this type of index is expected to correlate more closely with corresponding changes in the radiobiological hypoxic fraction than mean or median HbOlklvds, as has been disc in a previous theoretical study (Fenton et al., 1995 the most peripheral distance class (P = 0.019). For carbogen breathing, the percentage with > 25% HbO2 was again significantly increased for each of the first three distance classes (P = 0.0001, 0.0004, 0.0042 and 0.264). For the combination treatment, percentage with ) 25% HbO2 was significantly higher only for the first two distance classes (P =0.003, 0.013, 0.060 and 0.842). As with the KHT, no significant differences were found between the carbogen breathing and the combination treatment. In contrast to the KHT, however, no significant differences were observed between the NIC and the combination treatment for the SCCVII tumours.
To illustrate more clearly overall variations between the two tumour lines, Figure 5 presents the mean percentage with > 25% HbO2 averaged over the four distance classes. Overall the percentage of vessels with > 25% HbO2 was calculated by taking the mean percentage with > 25% HbO2 at each distance class, weighted by the corresponding tumour volume associated with that distance class for each tumour. This weighting compensates for the fact that the inner distance classes sample from smaller concentric shells of the Cwb_e-,acWinande e on tulow oxygention BM Fenton 947 tumour volume than at the outer distance classes. (Fenton and Siemann, 1994 (Fenton and Siemann, 1994) (Young et al., 1979; Vaupel and Mueller-Klieser, 1986) . Since the leg muscle would be expected to have higher oxygen requirements than the subcutaneous flank, it stands to reason that leg tumours should also tend to be better vascularised and oxygenated. It remains difficult to explain why the HbO, or pO2 levels do not correlate with the hypoxic fractions between the two sites, although, if the tumour cells surrounding the low-HbO. vessels in the flank are predominantly non-clonogenic, the resultant oxygen profiles would be lower in this site than in the leg without a corresponding increase in the radiobiological hypoxic fraction (Fenton et al., 1995) . (Chaplin et al., 1993) , and since the interior of these tumours remains very poorly oxygenated following the combination treatment, it follows that these interior tumour cells must be non-clonogenic to begin with and therefore irrelevant in terms of radiotherapy.
In a study using C3H mouse mammary carcinomas (Horsman et at., 1995), changes in the fraction of P02 readings S 5 mmHg generally correlated with the corresponding HFs following different oxygen manipulations. However, changes in tumour pO2 levels following NIC and carbogen were again inconsistent. Tumours were much better oxygenated following carbogen than NIC, in spite of equivalent radiosensitivities following either treatment. As was the case for the HbO2 measurements, pO2 levels following NIC were not different from the air-breathing controls. In the studies of Martin et al. (1994) (Moulder and Rockwell, 1984; Fenton et al., 1995) . As described more fully in a previous theoretical study (Fenton et al., 1995) , HF determinations can vary independently of directly measured changes in tumour oxygenation within the non-clonogenic subpopulation. Thus, if a higher proportion of non-clonogenic vs clonogenic cells is oxygenated following a given treatment, higher oxygen levels will be observed in relation to the corresponding reduction in cell survival.
Carbogen breathing is believed to improve tumour oxygenation primarily by increasing the diffiLsion distance of the oxygen from the blood vessels -thus the clonogenic anoxic cells at the edge of the previously oxygenated regions will be the first cells oxygenated. As the oxygen diffuses further, anoxic cells may be reached that have been without oxygen long enough to become non-clonogenic while remaining viable. Increasing the diffiusion distance enough to oxygenate these non-clonogenic cells results in an 'overkill' phenomenon in which no further enhancement of tumour radiosensitivity is realised in spite of the increased oxygen availability. Since the HF decreases in conjunction with the increase in tumour oxygenation following carbogen, an increase in oxygen delivery to some proportion of the clonogenic anoxic cells must also be occurring.
Previous work has suggested that NIC may act in part by reducing intermittent fluctuations in tumour blood flow . If this is the case, some of the tumour cells that are oxygenated following NIC will be those that were previously exposed to intermittent flow. It is reasonable that such acutely hypoxic cells would more likely remain clonogenic than cells that have been beyond the diffusion distance of oxygen for extended periods of time (chronic hypoxia). This implies that differences in the frequency of intermittent blood flow between tumour lines could directly influence the correlation between tumour oxygenation and radioresponse for these same tumour lines. Other evidence that NIC may act by reducing intermittent flow is provided by Lee and Song (1992) , who found that the effect of NIC administration was greater in large tumours than in small. They also attribute these differences to the fact that larger tumours are more likely to have intermittently opening blood vessels than small tumours (Chaplin et al., 1986; Trotter et al., 1989; Lord et al., 1993) .
But do such differences in intermittent flow exist between the KHT and SCCVH tumour lines? For SCCVII tumours, the number of blood vessels opening and closing over a 20 mm penod has been reported to be 10.3% , based on dual-staining techniques. In the KHT tumours, only 4% intermittently flowing vessels were observed (Fenton and Siemann, 1994) . Thus, in either case, a reduction in intermittent flow may have a relatively minor overall effect on tumour oxygenation. Although NIC-induced improvements in HbO2 levels were observed only in the peripheral vessels, Chaplin et al (1990) report that flow intermittencies are, in contrast, more prevalent in central tumour regions. However, their dual-staining techniques are only capable of measuring whether a given blood vessel contains active blood flow -not whether this flow is functional in terms of oxygen delivery (Fenton and Boyce, 1993) . Thus changes in dual-staining intermittency for blood vessels containing very low HbO2 levels may or may not relate to either tumour oxygenation or radioresponse. Since overall HbO2 levels were not substantially improved following NIC for either the KHT or the SCCVH, it appears unlikely that a NMC-induced decrease in acute hypoxia is the predominant mechanism for altenng radioresponse in either tumour model. This suggests that the beneficial effects of combining NIC and carbogen may not involve a decrease in acutely hypoxic cells in all cases.
Finally, why are SCCVH and KHT HbO2 levels increased so much more with carbogen than with NIC, despite similar effects on radiosensitivity? One possibility, is that, although both treatments may increase oxygen delivery to the clonogenic anoxic subpopulation, the carbogen may also tend to oxygenate some population of non-clonogenic anoxic cells. Following NIC, radioresponse increases with a minimal increase in oxygen availability, suggesting a redistribution of oxygen from non-clonogenic oxygenated cells to clonogenic anoxic cells. If NMC also reduces intermittent flow, then oxygen that was previously distributed to the non-clonogenic cells most distant from the previously open vessels will now be diverted to the clonogenic cells surrounding the newly opened vessels. Thus, less flow is now distributed among more vessels. This tends to decrease the oxygen diffusion distance while increasing oxygen delivery to the closest (and presumably clonogenic) tumour cells.
A final possible explanation for the NIC-induced radiosensitisation in the absence of significantly higher oxygen levels Cabo_md Ndcad -aide d on bmou uygnabon BM Fenton 9 q9q is the possibility that NIC may act by inhibiting radiationinduced potentially lethal damage repair. While this result has been demonstrated in vitro, further studies have suggested that repair inhibition is not the principle mechanism responsible for in vivo tumour radiosensitisation (Horsman et al.. 1987) .
In summary, it is clear that response to carbogen and NIC manipulation vanres substantially with tumour line in terms of both tumour radiosensitivity and direct measures of tumour oxygenation. The dilemma is that no currently available method exists for predicting whether or not a correlation will exist between the two measures in a given tumour. Thus defining an 'optimal' manipulative agent solely on the basis of its ability to increase tumour oxygenation may lead to erroneous conclusions. Contrary to some previous findings (Martin et al., 1994) , alterations in tumour oxygenation within a given tumour line may not be reflective of corresponding changes in tumour radiosensitivity if significantly different fractions of non-clonogenic tumour cells are involved. Further work is needed both to describe the underlying physiological basis for the observed discrepancies and to discover more representative methods for estimating tumour radioresponse following oxygen manipulation. In addition, better methods for quantiffying intermittencies in 'functional flow' are needed such that more subtle changes in tumour perfusion may be recognised.
